Sugarloaf Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Sugarloaf Wealth Management's NVO Position: Q3 2022 in Review
Sugarloaf Wealth Management sold out of Novo Nordisk (NVO) in Q3 2022, closing a stake of 600 shares — an estimated $33K sold.
Sugarloaf Wealth Management first reported a position in NVO in Q4 2019 and held it in 11 quarters. The position peaked at $34K in Q4 2021. 907 funds tracked by Wall St. Rank hold NVO as of Q3 2022.
- Sugarloaf Wealth Management reported no remaining Novo Nordisk position as of Q3 2022 after selling out during the quarter.
- Sugarloaf Wealth Management sold 600 Novo Nordisk shares in Q3 2022, an estimated $33K.
- Sugarloaf Wealth Management first reported a position in Novo Nordisk in Q4 2019 and held it in 11 quarters.
- Sugarloaf Wealth Management's Novo Nordisk position peaked at $34K in Q4 2021.
- 907 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2022.
Based on Sugarloaf Wealth Management's 13F filing for Q3 2022, filed 11 Oct 2022.